Pharmacokinetic interaction between regorafenib and atorvastatin in rats
CONCLUSIONS: This animal model study showed a significant pharmacokinetic interaction between regorafenib and atorvastatin. While this interaction may be clinically significant, this needs to be confirmed in clinical trials involving cancer patients.PMID:38632186 | DOI:10.1007/s43440-024-00570-z
Source: Pharmacological Reports - Category: Drugs & Pharmacology Authors: Danuta Szkutnik-Fiedler Edyta Sza łek Filip Otto Andrzej Czyrski Marta Kara źniewicz-Łada Anna Wolc Edmund Grze śkowiak Konrad Lewandowski Agnieszka Karbownik Source Type: research
More News: Atorvastatin Calcium | Cancer | Cancer & Oncology | Carcinoma | Cholesterol | Clinical Trials | Colorectal Cancer | Drugs & Pharmacology | Hepatocellular Carcinoma | Lipitor | Liver Cancer | Statin Therapy | Study | Zivast